CHOLF yields 2.68% · JNJ yields 2.13%● Live data
📍 CHOLF pulled ahead of the other in Year 1
Combined, CHOLF + JNJ cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of CHOLF + JNJ for your $10,000?
China Oilfield Services Limited, together with its subsidiaries, provides integrated offshore oilfield services in Mainland China and internationally. The company operates through four segments: Drilling Services, Well Services, Marine Support Services, and Geophysical Acquisition and Surveying Services. The Drilling Services segment provides jack-up drilling rig, semi-submersible drilling rig, modular rig, and land drilling rig services; and casting and tubing, and running pipe inspection and repair services. This segment operates and manages 36 jack-up drilling rigs, 12 semi-submersible drilling rigs, and 6 modular rigs. The Well Services segment offers onshore and offshore well services, including logging, drilling and completion fluids, directional drilling, cementing, well completion and workover, stimulation, and oilfield production optimization. The Marine Support Services segment offers anchor handling, towing of drilling rigs/engineering barges, oil lifting, offshore transportation, standby, firefighting, rescue, oil spill assisting, and other marine support services. It operates and manages approximately 130 vessels, including anchor-handling tug/supply, platform supply, and multi-purpose vessels, as well as barges and shuttle-tankers. The Geophysical Acquisition and Surveying Services segment provides marine seismic acquisition, offshore geo-surveying, seismic data processing and interpretation, and underwater engineering services. This segment owns 6 seismic vessels, 2 ocean bottle cable teams, and 5 engineering surveying vessels. China Oilfield Services Limited also issues bonds. The company is based in Sanhe, China. China Oilfield Services Limited is a subsidiary of China National Offshore Oil Corporation.
Full CHOLF Calculator →Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide, but strategically separated its Consumer Health business into Kenvue Inc. in 2023 to focus on its higher-growth, innovation-driven segments; the former Consumer Health brands (including TYLENOL, LISTERINE, and BAND-AID) are now owned by Kenvue. The company's core focus is now split between its Innovative Medicine (formerly Pharmaceutical) segment, which offers prescription products for complex diseases such as rheumatoid arthritis, various cancers, HIV/AIDS, and neurodegenerative disorders; and its MedTech (Medical Devices) segment, which provides advanced technology solutions including electrophysiology products, neurovascular care products, orthopaedics (hips, knees, spine), advanced surgery solutions, and disposable contact lenses under the ACUVUE brand. Company's two remaining segments primarily serve hospitals, healthcare professionals, wholesalers, and retailers, continuing its mission of advancing human health since its founding in 1886 and its current basing in New Brunswick, New Jersey.
Full JNJ Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.